These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6148880

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
    Danesh BJ, Brunton J, Sumner DJ.
    Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
    [Abstract] [Full Text] [Related]

  • 23. Nadolol versus band ligation for prevention of variceal bleeding.
    Mann NS.
    Gastrointest Endosc; 2004 Dec; 60(6):1036-7; author reply 1037. PubMed ID: 15605035
    [No Abstract] [Full Text] [Related]

  • 24. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R, Kravetz D, Fassio E, Ameigeiras B, Garcia D, Isla R, Landeira G, Dominguez N, Romero G, Argonz J, Terg R.
    Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A, Lledó JL, Rossi I, Pérez-Páramo M, Tabuenca MJ, Bañares R, Iborra J, Garrido A, Escartín P, Bosch J.
    Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
    Mols P, Hallemans R, Van Kuyk M, Melot C, Lejeune P, Ham H, Vertongen F, Naeije R.
    Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Renal effects of nadolol in cirrhosis.
    Gatta A, Sacerdoti D, Merkel C, Caregaro L, Borsato M, Bolognesi M, Ruol A.
    Eur J Clin Pharmacol; 1987 Feb; 33(5):473-7. PubMed ID: 3480806
    [Abstract] [Full Text] [Related]

  • 33. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C, Marin R, Sacerdoti D, Donada C, Cavallarin G, Torboli P, Amodio P, Sebastianelli G, Bolognesi M, Felder M, Mazzaro C, Gatta A.
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver.
    Cervinka J, Kordac V, Kalab M.
    J Int Med Res; 1989 Feb; 17(6):560-4. PubMed ID: 2628133
    [Abstract] [Full Text] [Related]

  • 40. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L, Bendtsen F, Hansen EF, Møller S.
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.